The cost effectiveness of hospital-based 25% podophyllin vs home-based 0.5% podophyllotoxin in the treatment of anogenital warts.
Lewis
D A
DA
Goldmeier
D
D
D003218:Condylomata Acuminata / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D011033:Podophyllin / Q000008:administration & dosage*; D011034:Podophyllotoxin / Q000008:administration & dosage*
D011033:Podophyllin; D011034:Podophyllotoxin